LENZ Stock Analysis: Buy, Sell, or Hold?
LENZ - LENZ Therapeutics, Inc. Common Stock
$15.82
-1.96 (-11.02%)
▼
WAIT
LOW Confidence
Last Updated: January 30, 2026
Earnings: Mar 18, 2026
Get Alerted When LENZ Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
1 traders called LENZ this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: LENZ is down 22.6% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: LENZ is down 22.6% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: LENZ is currently trading at $15.82, which is considered oversold relative to its 30-day fair value range of $15.83 to $19.17.
Technical Outlook: Technically, LENZ is in a strong downtrend. The price is currently testing key support at $16.36. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 11.0% recently.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $54.29 (+205.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, LENZ is in a strong downtrend. The price is currently testing key support at $16.36. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 11.0% recently.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $54.29 (+205.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$15.83 -
$19.17
Company Quality Score
47/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
77.4%
Protect Your Profits
Holding LENZ? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-11.0%)
- BULLISH: Trading 205.3% below Wall St target ($54.29)
- WARNING: Recommendation downgraded due to -22.6% 5-day decline - wait for stabilization
Fair Price Analysis
30-Day Fair Range
$15.83 -
$19.17
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$16.36
Resistance Level
$21.80
Current Trend
Strong Downtrend
Fundamental Context
Forward P/E (Next Year Est.)
-6.15
Wall Street Target
$54.29
(+205.3%)
Last updated: January 31, 2026 9:25 AM ET
Data refreshes hourly during market hours. Next update: 10:25 AM
Data refreshes hourly during market hours. Next update: 10:25 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is LENZ showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$22 | 60 HOLD |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1035 | 58 HOLD |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$83 | 57 HOLD |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$33 | 60 HOLD |
|
MRUS
Merus BV |
STRONG BUY
17 analysts |
$97 | 55 HOLD |
Advanced LENZ Option Strategies
Professional options setups generated by AI based on today's LENZ price and gamma walls.
